During Wednesday’s trading session, the shares of a company engaged in manufacturing and marketing of fertilisers surged nearly 15.3 percent to Rs. 303.49 on NSE, after reporting a rise in net profit by nearly 30 percent QoQ and 1284 percent YoY in Q3 FY25.
With a market cap of Rs. 2,421 crores, at 02:44 p.m., the shares of Madhya Bharat Agro Products Limited were trading in the green at Rs. 278.85, up by around 6 percent, as compared to its previous closing price of Rs. 263.16.
What’s the news
The fluctuations in the share prices were observed after Madhya Bharat Agro Products Limited announced the financial results for Q3 FY25, through the recent filings with the NSE.
For Q3 FY25, Madhya Bharat Agro Products reported revenue from operations of Rs. 283.7 crores, reflecting a marginal growth of around 2 percent QoQ from Rs. 278.3 crores in Q2 FY25, and increased by about 16.4 percent YoY from Rs. 243.7 crores in Q3 FY24.
The company’s net profit for Q3 FY25 grew to Rs. 18 crores, representing a rise of around 30.4 percent QoQ from Rs. 13.8 crores in Q2 FY25, and a year-on-year growth of nearly 1284.6 percent from Rs. 1.3 crores in Q3 FY24.
Also read….
Stock Performance
The stock has delivered negative returns of nearly 3 percent of returns in one year, while around 24 percent of positive returns in the last six months. However, the shares of Madhya Bharat Agro Products have gained around 27.2 percent in the last one month.
About the company
Madhya Bharat Agro Products Limited, a part of the Ostwal Group of Industries, is engaged in the business of manufacturing of phosphatic fertilizers and chemical products.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
